Modifiable cardiometabolic risk factors in youth with at-risk mental states: A cross-sectional pilot study.
Long-acting injectable antipsychotics for prevention and management of violent behaviour in psychotic patients.
A systematic review of evidence for fitness-to-drive among people with the mental health conditions of schizophrenia, stress/anxiety disorder, depression, personality disorder and obsessive compulsive disorder.
Resting state perfusion in the language network is linked to formal thought disorder and poor functional outcome in schizophrenia.
The role of stress-regulation genes in moderating the association of stress and daily-life psychotic experiences.
Self-Stigma Mediates the Impact of Insight on Current Suicide Ideation in Suicide Attempters with Schizophrenia: Results of a Moderated Mediation Approach.
Interaction of Brain-Derived Neurotrophic Factor Val66Met genotype and history of stress in regulation of prepulse inhibition in mice.
Effects of transcranial direct current stimulation on the auditory mismatch negativity response and working memory performance in schizophrenia: a pilot study.
Elevated hydroxylactam of hemopyrrole level in urine in perpetrators of extremely violent acts diagnosed with psychosis.
Paradoxical elevation of systemic inflammatory markers and physical activity in patients with schizophrenia.
Efficacy of fronto-temporal transcranial direct current stimulation for refractory auditory verbal hallucinations in schizophrenia: A randomized, double-blind, sham-controlled study.
Regional supply of outreach service and length of stay in psychiatric hospital among patients with schizophrenia: National case mix data analysis in Japan.
What do we know about insight into illness and its association with the underlying biology of schizophrenia?
The least worst option: user experiences of antipsychotic medication and lack of involvement in medication decisions in a UK community sample.
Interaction Between Val158Met Catechol-O-Methyltransferase Polymorphism and Social Cognitive Functioning in Schizophrenia: Pilot Study.
First-Episode Psychosis and the Criminal Justice System: Using a Sequential Intercept Framework to Highlight Risks and Opportunities.
Impact of Physician Follow-Up Care on Psychiatric Readmission Rates in a Population-Based Sample of Patients With Schizophrenia.
Simulated Effects of Policies to Reduce Diabetes Risk Among Adults With Schizophrenia Receiving Antipsychotics.
Understanding the Cost of a New Integrated Care Model to Serve CMHC Patients Who Have Serious Mental Illness.
Neuroplasticity and the brain connectome: what can Jean Talairach's reflections bring to modern psychosurgery?
The interplay of psychosis and victimisation across the life course: a prospective study in the general population.
Covariation between motor signs and negative symptoms in drug-naive subjects with schizophrenia-spectrum disorders before and after antipsychotic treatment.
Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority study.
Differential Cortical Gray Matter Deficits in Adolescent- and Adult-Onset First-Episode Treatment-Naïve Patients with Schizophrenia.
Comparing two schizophrenia-specific quality of life instruments in institutionalized people with schizophrenia.
A systematic meta-analysis of the association of Neuregulin 1 (NRG1), D-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia.
Admission to psychiatric hospital for mental illnesses 2 years prechildbirth and postchildbirth in Scotland: a health informatics approach to assessing mother and child outcomes.
Psychosocial stressors contributing to emergency psychiatric service utilization in a sample of ethno-culturally diverse clients with psychosis in Toronto.
Estimating the Prevalence of Serious Mental Illness and Dementia Diagnoses Among Medicare Beneficiaries in the Health and Retirement Study.
Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia.
Premorbid social adjustment and association with attenuated psychotic symptoms in clinical high-risk and help-seeking youth.
Central and non-central networks, cognition, clinical symptoms, and polygenic risk scores in schizophrenia.
Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.
Membrane cholesterol effect on the 5-HT2A receptor: Insights into the lipid-induced modulation of an antipsychotic drug target.
Responding to Ten Common Delirium Misconceptions With Best Evidence: An Educational Review for Clinicians.
On the integrity of functional brain networks in schizophrenia, Parkinson's disease, and advanced age: Evidence from connectivity-based single-subject classification.
WNT/β-Catenin Pathway and Epigenetic Mechanisms Regulate the Pitt-Hopkins Syndrome and Schizophrenia Risk Gene TCF4.
Human Brain Imaging of Nicotinic Acetylcholine α4β2* Receptors using [(18) F]Nifene: Selectivity, Functional Activity, Toxicity, Aging Effects, Gender Effects and Extrathalamic Pathways.
Meeting in difference: Revisiting the therapeutic relationship based on patients' and therapists' experiences in several clinical contexts.
Improved Metabolic and Psychiatric Outcomes with Discontinuation of Atypical Antipsychotics in Youth Hospitalized in a State Psychiatric Facility.
Cancer screening participation in schizophrenic outpatients and the influence of their functional disability on the screening rate: A cross-sectional study in Japan.
Modelling the neuromotor abnormalities of psychotic illness: Putative mechanisms and systems dysfunction.
Is the association between offspring intelligence and parents' educational attainment influenced by schizophrenia or mood disorder in parents?
Identification of an argpyrimidine-modified protein in human red blood cells from schizophrenic patients: A possible biomarker for diseases involving carbonyl stress.
A new generation computerised metacognitive cognitive remediation programme for schizophrenia (CIRCuiTS): a randomised controlled trial.
Post-fall reporting in aged acute inpatient mental health units: an 18-month observational cohort study.
Effects of cognitive remediation on negative symptoms dimensions: exploring the role of working memory.
CBT in the prevention of psychosis and other severe mental disorders in patients with an at risk mental state: A review and proposed next steps.
Profiling of experiential pleasure, emotional regulation and emotion expression in patients with schizophrenia.
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.
The neuropsychology and neurobiology of late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: a critical review.
The methylazoxymethanol acetate rat model: molecular and epigenetic effect in the developing prefrontal cortex: An Editorial Highlight for 'Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM
Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal state of schizophrenia through epigenetic changes in nuclear receptor genes.
GPX1 Pro198Leu polymorphism and GSTP1 Ile105Val polymorphisms are not associated with the risk of schizophrenia in the Chinese Han population.
Protocol for a qualitative study exploring perspectives on the INternational CLassification of Diseases (11th revision); Using lived experience to improve mental health Diagnosis in NHS England: INCLUDE study.
A combined VBM and DTI study of schizophrenia: bilateral decreased insula volume and cerebral white matter disintegrity corresponding to subinsular white matter projections unlinked to clinical symptomatology.
A novel relationship for schizophrenia, bipolar and major depressive disorder Part 3: evidence from chromosome 3 high density association screen.
White matter fiber integrity of the saccadic eye movement network differs between schizophrenia and healthy groups.
Association between mitochondrial DNA variations and schizophrenia in the northern Chinese Han population.
Erratum: Uniting the neurodevelopmental and immunological hypotheses: Neuregulin 1 receptor ErbB and Toll-like receptor activation in first-episode schizophrenia.
Oral Aripiprazole as Maintenance Treatment in Adolescent Schizophrenia: Results From a 52-Week, Randomized, Placebo-Controlled Withdrawal Study.
Effects of oral versus long-acting antipsychotics on social functioning: A psychiatrists' survey in India.
Evidence for altered cell membrane lipid composition in postmortem prefrontal white matter in bipolar disorder and schizophrenia.
The Microbiome as a Key Regulator of Brain, Behaviour and Immunity: Commentary on the 2017 Named Series.
Inflammation, substance use, psychopathology, and cognition in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
Deficits in visual working-memory capacity and general cognition in African Americans with psychosis.
'No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia': authors' response.
A state-independent network of depressive, negative and positive symptoms in male patients with schizophrenia spectrum disorders.
Correlation of Caregiver Burden and Baseline Characteristics of Caregivers and Patients in Their Care with Recent-Onset Psychosis: The FIRST Study.
Physical activity is associated with the physical, psychological, social and environmental quality of life in people with mental health problems in a low resource setting.
Maternal infection and anemia as prenatal predisposing factors for schizophrenia: The link with zinc deficiency.
Targeting recovery in first episode psychosis: The importance of neurocognition and premorbid adjustment in a 3-year longitudinal study.
Temporal stability of self-disorders and longitudinal unfolding of symptom dimensions: A complementary analysis.
Do trauma-focussed psychological interventions have an effect on psychotic symptoms? A systematic review and meta-analysis.
Severe clinical events in 100 patients with schizophrenia: a retrospective clinical description using a system-specific psychopathological approach.
Trait aspects of auditory mismatch negativity predict response to auditory training in individuals with early illness schizophrenia.
The Role of Conformity in Relation to Cohesiveness and Intimacy in Day-Hospital Groups of Patients with Schizophrenia.
Baseline Demographics and Characteristics From a Paliperidone Palmitate Study in Subjects with Recent-Onset Schizophrenia or Schizophreniform Disorder.
A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil.
Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil.
Clozapine-Induced Microseizures, Orofacial Dyskinesia, and Speech Dysfluency in an Adolescent with Treatment Resistant Early Onset Schizophrenia on Concurrent Lithium Therapy.
Graves' Thyrotoxicosis Presenting as Schizophreniform Psychosis: A Case Report and Literature Review.
[Analysis of early response to the antipsychotic treatment and related factors in acute schizophrenia patients].
Parental hospital-treated somatic illnesses and psychosis of the offspring-The Northern Finland Birth Cohort 1986 study.
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder.
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder.
Psychometric properties of three measures assessing advanced theory of mind: Evidence from people with schizophrenia.
Exploring online communication about cigarette smoking among Twitter users who self-identify as having schizophrenia.
The Atypical MAP Kinase SWIP-13/ERK8 Regulates Dopamine Transporters Through a Rho-Dependent Mechanism.
Blink rate is associated with drug-induced parkinsonism in patients with severe mental illness, but does not meet requirements to serve as a clinical test: the Curacao extrapyramidal syndromes study XIII.
Only a small proportion of patients with first episode psychosis come via prodromal services: a retrospective survey of a large UK mental health programme.
Untangling the complex relationships between symptoms of schizophrenia and emotion dynamics in daily life: Findings from an experience sampling pilot study.
Cost-effectiveness of early intervention services for psychosis and fidelity to national policy implementation guidance.
Greater Metacognition and Lower Fear of Negative Evaluation: Potential Factors Contributing to Improved Stigma Resistance among Individuals Diagnosed with Schizophrenia.
Average Spectral Power Changes at the Hippocampal Electroencephalogram in Schizophrenia Model Induced by Ketamine.
Mediating effects of self-stigma on the relationship between perceived stigma and psychosocial outcomes among psychiatric outpatients: findings from a cross-sectional survey in Singapore.
FTBMT, a novel and selective GPR52 agonist, demonstrates antipsychotic-like and procognitive effects in rodents revealing a potential therapeutic agent for schizophrenia.
An experience sampling study on the ecological validity of the SWN-20: Indication that subjective well-being is associated with momentary affective states above and beyond psychosis susceptibility.
Ethical acceptability of offering financial incentives for taking antipsychotic depot medication: patients' and clinicians' perspectives after a 12-month randomized controlled trial.
Social network confidants, duration of untreated psychosis and cannabis use in people with first episode psychosis: An exploratory study.
'People with Problems, Not Patients with Illnesses': Using Psychosocial Frameworks to Reduce the Stigma of Psychosis.
Letter to the Editor: The half-alive concept of schizophrenia is still better than the spectrum of everything.
Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia-New Developments and Future Perspective.
A commentary: Do specific gene risk variants for schizophrenia contribute similarly to the incidence of schizophrenia world-wide?
Affective reactivity to daily life stress: Relationship to positive psychotic and depressive symptoms in a general population sample.
Suicide Attempt, Clinical Correlates, and BDNF Val66Met Polymorphism in Chronic Patients With Schizophrenia.
Preliminary study of higher-order language and extralinguistic impairments in individuals with high clinical risk of psychosis and first episode of schizophrenia.
Association between psychosis phenotype and APOE genotype on the clinical profiles of Alzheimer's disease.
Effect of melatonin in reducing second-generation antipsychotic metabolic effects: A double blind controlled clinical trial.
Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a meta-analysis of randomized controlled trials.
The Structure and Measurement of Unusual Sensory Experiences in Different Modalities: The Multi-Modality Unusual Sensory Experiences Questionnaire (MUSEQ).
Accounting for group differences in study retention in a randomized trial of specialized treatment for first episode psychosis.
Analysis of proarrhythmic potential of an atypical antipsychotic drug paliperidone in the halothane-anesthetized dogs.
A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains.
Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study.
Genome-wide significant locus for Research Diagnostic Criteria Schizoaffective Disorder Bipolar type.
The effect of adjunctive telmisartan treatment on psychopathology and cognition in patients with schizophrenia.
Differential DNA methylation at birth associated with mental disorder in individuals with 22q11.2 deletion syndrome.
PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia.
Elemental fingerprinting of schizophrenia patient blood plasma before and after treatment with antipsychotics.
Corynebacterium kroppenstedtii Is an Emerging Cause of Mastitis Especially in Patients With Psychiatric Illness on Antipsychotic Medication.
Subacute Sclerosing Panencephalitis Presenting with Isolated Positive Psychotic and Catatonic Symptoms.
Resolution of Cognitive Adverse Effects of Electroconvulsive Therapy in Persons with Schizophrenia: A Prospective Study.